Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

NCT01301040 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Slow recruitment

Conditions

Breast Cancer

Interventions

DRUG: epirubicin, cyclophosphamide, docetaxel

Sponsor

Jules Bordet Institute

Collaborators

[object Object]